Skip to content

Clinical trials

Homozygous Familial Hypercholesterolemia trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Homozygous Familial Hypercholesterolemia Country / region: Taiwan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20141
20151
20171
20181
20191
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Kastle Therapeutics, LLC2
Regeneron Pharmaceuticals2
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Homozygous Familial Hypercholesterolemia10
Hyperlipidemias5
Hypercholesterolemia4
Hyperlipoproteinemia Type II4
Dyslipidemias3
Congenital Abnormalities2
Genetic Diseases, Inborn2
Hyperlipoproteinemias2
Infant, Newborn, Diseases2
Lipid Metabolism Disorders2

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.